Announcement PDF ® IMAGION BIOSYSTEMS LIMITED (ASX: IBX) 6 February 2023 Investor Webinar MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce that an investor webinar will be held tomorrow to provide additional details and answer questions in relation to today’s Company update. Please note the link in the company update contained an error – the link below should be used to register for the webinar. The Company will be hosting a Fireside Chat Webinar on Tuesday, February 7th, at 12:00pm AEDT (Syd/Melb) to provide additional details and answer questions. To register a seat in our live webinar and for extended information about this announcement, including FAQs visit: https://imagionbiosystems.com/our-technology/technology-shift-faqs/ -ENDS About Imagion Biosystems Imagion Biosystems is developing a new non-radioactive and safe diagnostic imaging technology. Combining biotechnology and nanotechnology, the Company aims to detect cancer and other diseases earlier and with higher specificity than is currently possible. Imagion Biosystems listed on the Australian Securities Exchange (ASX) in June 2017. For further information please visit www.imagionbiosystems.com Authorisation & Additional information This announcement was authorised by the Company Secretary of Imagion Biosystems Limited. U.S. Media Contact: Casie Ost Casie.ost@imagionbio.com +1-619-693-4428 Australian Media & Investor Relations: Hannah Howlett, WE Communications We-AUImagionBiosystems@we-worldwide.com +61 (0) 450648064 Imagion Biosystems Limited ACN 616 305 027 Level 25, 525 Collins Street, Melbourne VIC 3000 www.imagionbiosystems.com